Veran Medical Technologies, an Overland-based company that makes tools to help with cancer diagnosis, has announced a $20 million investment from BTG, a health care company based in the United Kingdom.
The agreement gives BTG the option to buy Veran starting in January 2020.
The funding aims to boost new Veran efforts focused on treating lung cancer.
BTG focuses on products that help physicians perform minimally invasive medical procedures, and it owns a portfolio of companies in that space.
Veran now has raised nearly $100 million since it moved to St. Louis in 2013.
Read more: St. Louis Business Journal